Your browser doesn't support javascript.
loading
Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery.
Castle, Michael J; Baltanás, Fernando C; Kovacs, Imre; Nagahara, Alan H; Barba, David; Tuszynski, Mark H.
Afiliación
  • Castle MJ; Department of Neurosciences, University of California, San Diego, La Jolla, California.
  • Baltanás FC; Department of Neurosciences, University of California, San Diego, La Jolla, California.
  • Kovacs I; Department of Neurosciences, University of California, San Diego, La Jolla, California.
  • Nagahara AH; Department of Neurosciences, University of California, San Diego, La Jolla, California.
  • Barba D; Department of Neurosurgery, University of California, San Diego, La Jolla, California.
  • Tuszynski MH; Department of Neurosciences, University of California, San Diego, La Jolla, California.
Hum Gene Ther ; 31(7-8): 415-422, 2020 04.
Article en En | MEDLINE | ID: mdl-32126838

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia Genética / Técnicas de Transferencia de Gen / Dependovirus / Factor de Crecimiento Nervioso / Enfermedad de Alzheimer / Vectores Genéticos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Gene Ther Asunto de la revista: GENETICA MEDICA / TERAPEUTICA Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia Genética / Técnicas de Transferencia de Gen / Dependovirus / Factor de Crecimiento Nervioso / Enfermedad de Alzheimer / Vectores Genéticos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Gene Ther Asunto de la revista: GENETICA MEDICA / TERAPEUTICA Año: 2020 Tipo del documento: Article